Tag: Agreement
Emcure Pharma and Roche sign dstribution agreement to strengthen nephrology &...
Under the agreement, which will be effective April 1, 2026, Emcure will distribute Roche’s established and globally recognised brands in the nephrology and transplant segment in India
Beyond Trade: How the EU–India FTA reshapes life-sciences industry
The deal represents nearly 25% of global GDP and one-third of global trade, making it one of the most consequential trade agreements of this era
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
This strategic alliance aims to accelerate the availability of high-quality, cost-effective biosimilar Certolizumab Pegol to patients worldwide.
United States withdraws from WHO: Analyzing the impact & way forward
The United States’ contributions account for approximately 15% of the WHO’s budget
Healthium Medtech & HSSC sign MoU to enhance skill development in...
Strategic partnership to offer specialized training and certification programs for skilling, reskilling and upskilling healthcare professionals across India
OmniActive acquires ENovate Biolife
This transaction marks OmniActive’s second strategic expansion, following its purchase of Bangalore-based botanical ingredients company IndFrag in 2017
Biocon Biologics secures market entry for its Bmab 1200 Biosimilar in...
Under the terms of this settlement agreement, Biocon Biologics has resolved patent disputes with Janssen to secure market entry dates in Europe, the UK, Canada, and Japan
Alkem MedTech partners Exactech to manufacture & market knee-hip replacement implants...
This collaboration marks the first of its kind in the musculoskeletal space in India, providing Alkem MedTech with access to the design, manufacturing expertise, and marketing rights of Exactech's globally-recognized brands
GSK acquires oligonucleotide drug startup Elsie
This follows a successful research collaboration with Elsie, announced in July 2023, in which GSK was able to explore and validate the technology
Glenmark to sell BeiGene’s oncology medicines, Tislelizumab and Zanubrutinib in India
Under this strategic collaboration, Glenmark will be responsible for locally required development, registration and distribution providing access to BeiGene's innovative oncology medicines for cancer patients across India